Koers SoftOx Solutions AS Oslo Bors
Aandelen
NO0010811961
Biotechnologie & Medisch Onderzoek
Omzet 2021 | 7,9 mln. 727K 676K | Omzet 2022 | 7,11 mln. 655K 608K | Marktkapitalisatie | 241 mln. 22,18 mln. 20,6 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2021 | -65 mln. -5,98 mln. -5,56 mln. | Nettowinst (verlies) 2022 | -71 mln. -6,53 mln. -6,07 mln. | EV/omzet 2021 | 64,3 x |
Nettoliquiditeiten 2021 | 56,98 mln. 5,24 mln. 4,87 mln. | Nettoliquiditeiten 2022 | 6,91 mln. 636K 590K | EV/omzet 2022 | 32,9 x |
K/w-verhouding 2021 |
-8,86
x | K/w-verhouding 2022 |
-3,39
x | Werknemers | - |
Dividendrendement 2021 * |
-
| Dividendrendement 2022 |
-
| Vrij verhandelbaar | 96,54% |
Recentste transcriptie over SoftOx Solutions AS
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | - | - | |
Geir Almås
FOU | Founder | - | 21-06-12 |
Harald Sætvedt
DFI | Director of Finance/CFO | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Olav Jarlsby
BRD | Director/Board Member | - | 17-04-15 |
Geir Almås
FOU | Founder | - | 21-06-12 |
Adrian Bignami
BRD | Director/Board Member | - | - |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-1,47% | 103 mld. | |
+9,04% | 101 mld. | |
+4,40% | 23,07 mld. | |
-12,18% | 22,23 mld. | |
-4,36% | 18,05 mld. | |
-39,98% | 17,18 mld. | |
-10,23% | 16,94 mld. | |
+6,84% | 14,07 mld. | |
+38,66% | 12,35 mld. |